How a Small and Young Foundation Catalyzed Research into a Rare Disease

Susan Ruediger, founder and CEO of CMT Research Foundation, discusses her organization’s efforts to catalyze drug development for Charcot-Marie Tooth disease, what it’s done to address obstacles, and some of the partnerships it has established to advance the development of treatments and potentially a cure.